# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-26T22:33:17.267128

---

**Idea Fidelity**

The paper proceeds partly from the original essay: it exploits staggered affirmative action bans across multiple states and applies modern DiD estimators to IPEDS institutional data, highlighting the TWFE bias that undercut Hinrichs (2012). However, the execution diverges from the manifest in important respects. The data sample now excludes early adopters (California, Washington, Florida) because the 2002–2022 IPEDS panel lacks pre-treatment observations for them; the manifest emphasized nine bans (including those states) and a broader cascade + earnings analysis, none of which materialize here. The promised cascade mechanism across institutions of differing selectivity tiers, and the downstream earnings evidence from ACS, are absent. These omissions weaken the link between the stated research agenda and the empirical implementation.

**Summary**

This paper reexamines the impact of state-level affirmative action bans on minority enrollment in public four-year universities, using modern staggered-DiD estimators (Callaway-Sant’Anna and Sun-Abraham) on IPEDS panels from 2002–2022. The corrected estimates show that bans reduce combined Black and Hispanic shares by roughly 3.2 percentage points, effects that are much larger than those from conventional TWFE regressions—and are robust to alternative estimators, outcomes, and leave-one-out checks. The paper argues that the prior consensus of “small effects” reflected TWFE bias rather than substantive evidence.

**Essential Points**

1. **Sample limitation and external validity:** Because the analysis excludes the three earliest-ban states (CA, WA, FL), the paper no longer studies all nine state bans and therefore cannot empirically speak to the full policy process that motivated the manifest. The early bans may differ systematically (size, institutional mix, population) from later ones, so the headline 3.2 percentage points effect may not generalize to national policy inferences. The authors should justify how excluding the earliest bans affects their identification strategy and external claims—especially given the original policy claim is about national effects and the SFFA decision referenced in the introduction.

2. **Omitted cascade and earnings analyses promised in the manifest:** The idea emphasized enrollment cascades across tiers of selectivity and downstream earnings effects via ACS, yet the paper contains neither. Without these sections, the paper falls short of its declared research agenda. If the data or feasible identification for these outcomes proved infeasible, that should be transparently explained; if not, those analyses should be added or at least sketched (with the corresponding estimation issues and results) so that the paper fulfills its original scope.

3. **Event-study and placebo interpretation:** The dynamic effects table reports non-zero pre-trend coefficients (e.g., a large positive ATT at \(t-5\) and some significant coefficients before treatment), yet the text asserts support for parallel trends. These pre-trends are either noise or suggest that the parallel-trends assumption may not hold uniformly across cohorts. The authors should clarify how they interpret these pre-treatment coefficients, present joint tests for no pre-trends, and, if needed, adjust the specification (e.g., restrict to cohorts with cleaner trends or control for anticipatory effects). Similarly, the placebo on White share is only reported as insignificant, but the point estimate is positive—with TWFE showing a positive placebo as well. Given concerns about compositional change, more discussion on whether White share movements confound the interpretation is necessary.

If addressing these three points requires substantial new data and analysis, the authors should consider whether the current paper is premature; otherwise, the paper risks failing to deliver on its stated contributions.

**Suggestions**

1. **Restore or explain deviations from original scope:**
   - If data limitations truly prevent inclusion of CA, WA, and FL, explicitly discuss how this truncation affects the conclusions. For example, compare demographic/institutional characteristics of excluded states to those analyzed, possibly via a descriptive appendix. This would help readers gauge whether the six-state sample reflects the broader policy environment.
   - If feasible, consider leveraging earlier IPEDS or supplementary data (e.g., state-level reports, NCES data pre-2002) to include California/Washington/Florida at least in the enrollment analysis; even if pre-treatment data are sparse, a sensitivity check using fewer pre-periods could provide valuable evidence on whether the effects seen in the later bans are similar to the early bans.
   - Alternatively, reframe the paper’s claim to focus on the second wave of bans (2007 onward) if those are the only ones that can be credibly studied. That reframing should appear in the introduction and conclusion to align the narrative with the empirical sample.

2. **Add cascade and earnings analyses or explain their omission:**
   - For the cascade mechanism: stratify institutions by pre-ban selectivity or by flagship vs. regional status (as mentioned in the manifest). Estimate heterogeneous ATTs across these strata using Callaway-Sant’Anna. If data limitations (e.g., lack of selectivity measures) prevent this, describe the barrier and perhaps use proxies (e.g., institutional size, Pell share) to speak to sorting effects.
   - For earnings: combine the IPEDS results with ACS data to examine whether bans led to declines in Black/Hispanic earnings at the state level, controlling for cohort flows. A natural approach is a state-year staggered-DiD with state-level earnings (log median income) as the outcome, perhaps interacting treatment with educational attainment shares. If the required identification (e.g., sufficient pre-periods) is weak, explain why this analysis was deferred or provide at least suggestive correlations (e.g., time series plots).
   - Even if full cascade/earnings analyses are infeasible, include a section describing the intended mechanism, why it matters, and what future research could do—so the paper still acknowledges the manifest goals and lays out a research agenda.

3. **Strengthen dynamic and placebo diagnostics:**
   - Re-estimate the event study with a joint pre-trend test (e.g., \(F\)-test that all pre-treatment coefficients equal zero) and report the exact \(p\)-value. If the significant coefficients (e.g., \(t-5\)) persist, consider trimming the event window or controling for differential pre-trends across cohorts (e.g., by allowing cohort-specific linear trends). Discuss how any anticipatory behavior (e.g., policy debates causing earlier enrollment shifts) might influence the estimates.
   - Expand placebo analyses beyond the White share. For example, test whether bans affect shares of Asian or Native American students, or enrollment in sectors unlikely to respond (e.g., community colleges outside the ban states). These extra placebos would bolster confidence that the effects are genuinely driven by the intended treatment and not by broader compositional changes.
   - Clarify why the White share placebo point estimate is positive (not statistically significant) and whether that is expected under compositional substitution (e.g., White share rises because total enrollment declines disproportionately).

4. **Deepen discussion of mechanisms and magnitude:**
   - Provide a back-of-the-envelope calculation translating the 3.2 percentage point decline into student counts, possibly varying by institution size or state. This would anchor the policy relevance and help readers interpret the standardized effect sizes presented in the appendix.
   - Discuss the potential channels for the decline: is it primarily driven by decreases in admits, acceptances, or matriculation? While admissions data may not be available, connecting the results to related literature (e.g., on holistic review, yield rates) would enrich the story.
   - Consider exploring whether the effects differ by institution selectivity (even if only by simple size or flagships vs. others). This would connect back to the “cascade” idea and allow a nuanced conclusion about where representation falls the most when bans take effect.

5. **Methodological transparency:**
   - Detail the covariates used in the doubly-robust estimator. Are there additional controls (e.g., economic conditions, demographic trends) included in the outcome regression or propensity score? Presenting these details (even in an appendix) would improve reproducibility and let readers assess the credibility of the parallel trends assumption.
   - Describe how the comparator group (never-treated institutions) compares to treated institutions on pre-treatment characteristics. Even if never-treated units are used, readers will want to know how comparable they are. If substantial differences exist, the not-yet-treated sensitivity check is helpful—consider expanding it by matching on pre-treatment levels or trends.
   - Clarify the clustering strategy: the paper clusters standard errors at the state level, but institutions within the same state likely share policy shocks. Explain how inference is affected by the small number of treated states (six) and whether wild cluster bootstrap or other methods were considered.

6. **Visual presentation:**
   - Include figures of the event study (with confidence intervals) rather than just the table so readers can quickly assess pre-trend dynamics and effect evolution.
   - Plot cohort-specific ATTs over time to illustrate heterogeneity and to show whether later cohorts converge to similar magnitudes.

By addressing these points, the paper would better align with its original promise, strengthen causal claims, and provide a richer understanding of the downstream consequences of affirmative action bans on the racial composition of public universities.
